Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 7701 | 1259 | 41.3 | 83% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 21 | 35063 | OSTEOPOROSIS//OSTEOPOROSIS INTERNATIONAL//BONE MINERAL DENSITY |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TERIPARATIDE | Author keyword | 135 | 51% | 15% | 188 |
| 2 | PTH | Author keyword | 13 | 12% | 8% | 103 |
| 3 | REG BONE | Address | 10 | 26% | 3% | 32 |
| 4 | INTERMITTENT PTH | Author keyword | 8 | 100% | 0% | 5 |
| 5 | RHPTH | Author keyword | 7 | 67% | 0% | 6 |
| 6 | CIZ | Author keyword | 6 | 80% | 0% | 4 |
| 7 | OVARIECTOMIZED RHESUS MONKEY | Author keyword | 6 | 80% | 0% | 4 |
| 8 | CONTINUOUS PTH | Author keyword | 6 | 100% | 0% | 4 |
| 9 | MAINE OSTEOPOROSIS | Address | 5 | 54% | 1% | 7 |
| 10 | HPTH1 34 | Author keyword | 4 | 67% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | TERIPARATIDE | 135 | 51% | 15% | 188 | Search TERIPARATIDE | Search TERIPARATIDE |
| 2 | PTH | 13 | 12% | 8% | 103 | Search PTH | Search PTH |
| 3 | INTERMITTENT PTH | 8 | 100% | 0% | 5 | Search INTERMITTENT+PTH | Search INTERMITTENT+PTH |
| 4 | RHPTH | 7 | 67% | 0% | 6 | Search RHPTH | Search RHPTH |
| 5 | CIZ | 6 | 80% | 0% | 4 | Search CIZ | Search CIZ |
| 6 | OVARIECTOMIZED RHESUS MONKEY | 6 | 80% | 0% | 4 | Search OVARIECTOMIZED+RHESUS+MONKEY | Search OVARIECTOMIZED+RHESUS+MONKEY |
| 7 | CONTINUOUS PTH | 6 | 100% | 0% | 4 | Search CONTINUOUS+PTH | Search CONTINUOUS+PTH |
| 8 | HPTH1 34 | 4 | 67% | 0% | 4 | Search HPTH1+34 | Search HPTH1+34 |
| 9 | ANABOLIC | 4 | 15% | 2% | 26 | Search ANABOLIC | Search ANABOLIC |
| 10 | PTH 1 84 | 4 | 56% | 0% | 5 | Search PTH+1+84 | Search PTH+1+84 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PARATHYROID HORMONE 1 34 | 135 | 48% | 17% | 209 |
| 2 | SEXUALLY MATURE | 77 | 96% | 2% | 24 |
| 3 | HUMAN PARATHYROID HORMONE 1 34 | 68 | 84% | 3% | 37 |
| 4 | TERIPARATIDE | 51 | 41% | 8% | 98 |
| 5 | HPTH 1 34 | 45 | 94% | 1% | 16 |
| 6 | AGED OVARIECTOMIZED RATS | 30 | 57% | 3% | 35 |
| 7 | ANTIRESORPTIVE AGENTS ESTROGEN | 28 | 81% | 1% | 17 |
| 8 | FRACTURE HEALING PROCESS | 26 | 87% | 1% | 13 |
| 9 | HUMAN PTH1 34 | 23 | 86% | 1% | 12 |
| 10 | FRACTURE RISK REDUCTION | 22 | 53% | 2% | 29 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Molecular and cellular mechanisms of the anabolic effect of intermittent PTH | 2007 | 235 | 108 | 61% |
| Parathyroid hormone analogues in the treatment of osteoporosis | 2011 | 27 | 70 | 83% |
| The Role of Recombinant PTH in Human Fracture Healing: A Systematic Review | 2014 | 6 | 26 | 77% |
| Treatment of post-menopausal osteoporosis: beyond bisphosphonates | 2015 | 2 | 97 | 25% |
| Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use | 2005 | 266 | 79 | 51% |
| Mechanisms of anabolic therapies for osteoporosis | 2007 | 208 | 68 | 35% |
| Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis | 2015 | 1 | 92 | 37% |
| Endogenous tissue engineering: PTH therapy for skeletal repair | 2012 | 13 | 42 | 79% |
| Parathyroid hormone: a double-edged sword for bone metabolism | 2004 | 116 | 49 | 61% |
| Parathyroid Hormone and Bone Healing | 2010 | 27 | 51 | 76% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | REG BONE | 10 | 26% | 2.5% | 32 |
| 2 | MAINE OSTEOPOROSIS | 5 | 54% | 0.6% | 7 |
| 3 | BIOPHARM DEV UNIT | 3 | 100% | 0.2% | 3 |
| 4 | BRANCH MARINE BIOPHARMACEUT | 3 | 100% | 0.2% | 3 |
| 5 | PROJECT BONE METAB DIS | 3 | 60% | 0.2% | 3 |
| 6 | CLIN ORG PHARMACEUT PROD | 2 | 67% | 0.2% | 2 |
| 7 | EXPT PATHOL TISSUE ENGN | 2 | 67% | 0.2% | 2 |
| 8 | BONE STEM CELLS | 2 | 18% | 0.6% | 8 |
| 9 | ADV BONE JOINT SCI | 1 | 100% | 0.2% | 2 |
| 10 | DEV EXCELLENCE J AN | 1 | 50% | 0.2% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000152311 | OSTEOPOROSIS INDUCTION//CHAIR SURG PATHOPHYSIOL//OST 6 OSTEOCARE |
| 2 | 0.0000144566 | ALENDRONATE//RISEDRONATE//BISPHOSPHONATES |
| 3 | 0.0000128973 | SCLEROSTIN//SOST//LRP5 |
| 4 | 0.0000114075 | HDR SYNDROME//KENNY CAFFEY SYNDROME//HYPOPARATHYROIDISM |
| 5 | 0.0000111957 | PARATHYROID HORMONE RELATED PROTEIN//PTHRP//PARATHYROID HORMONE RELATED PEPTIDE |
| 6 | 0.0000104380 | STRONTIUM RANELATE//STRONTIUM CONTAINING HYDROXYAPATITE//CALCIUM POLYPHOSPHATE |
| 7 | 0.0000098884 | PTH ASSAYS//WHOLE PTH//INTACT PTH |
| 8 | 0.0000071848 | GROWTH HORMONE BIOL//IN SITU SETTING CEMENT//POLYD L LACTIDE COATING |
| 9 | 0.0000070507 | POSITIVE BONE BALANCE//PROSTAGLANDIN ESTRADIOL PGE2//ENDOCRINOL METAB MC1850 |
| 10 | 0.0000070411 | TRABECULAR BONE//HR PQCT//CANCELLOUS BONE |